CRH's $8.5B Arcosa deal is likely to expand its aggregates footprint, boost infrastructure exposure and deliver synergies despite integration risks.

Arcosa, Inc. (ACA) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the current forward P/E of 33.78 appears difficult to justify given the recent shift to negative operating margins and the ongoing volatility in cash flow generation.
Arcosa, Inc. (ACA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Arcosa, Inc. (ACA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.51vs $0.13+292.3% | $572Mvs $642M-11.0% |
| Q1 2026 | Feb 26, 2026 | $1.15vs $0.95+21.1% | $717Mvs $719M-0.4% |
| Q4 2025 | Oct 30, 2025 | $1.56vs $1.33+17.3% | $798Mvs $719M+10.9% |
| Q3 2025 | Aug 7, 2025 | $1.27vs $1.05+21.0% | $737Mvs $775M-4.9% |
Recent stock market news and headlines for Arcosa, Inc. (ACA)
CRH's $8.5B Arcosa deal is likely to expand its aggregates footprint, boost infrastructure exposure and deliver synergies despite integration risks.

NEW YORK--(BUSINESS WIRE)--ACA Group (ACA), the leading governance, risk, and compliance (GRC) advisor in financial services, has established its newest office in Durham, North Carolina. The new location serves as ACA's innovation and technology center, housing a growing team of engineers, data scientists, and product developers focused on advancing ComplianceAlpha®, ACA's compliance technology platform. On May 4, 2026, the doors officially opened at the Durham office, which marks a significant.

On June 22, 2026, Arcosa Inc (ACA) shares experienced a notable increase of 6.7%, bringing the current price to $144.90. The stock has shown impressive price pe

Key metrics vs top competitors for Arcosa, Inc. (ACA)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $145.29 | $7.13B | 34.27 | 12.2% | 7.23% | 8.25% | 0.14% | |
| $576.70 | $34.78B | 30.68 | 0.12% | 38.67% | 25.07% | — | |
| $295.01 | $38.28B | 36.33 | 6.94% | 13.88% | 13.07% | — | |
| $107.00 | $71.5B | 19.42 | 9.01% | 9.04% | 22.18% | — | |
| $34.58 | $2.76B | 11.34 | -29.95% | 12.37% | 21.27% | — | |
| $1.70 | $77.42M | -4.25 | 69.76% | -13.44% | -314.53% | — |
Arcosa, Inc. (ACA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Arcosa, Inc. (ACA) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 30, 2026·SEC
Apr 1, 2026·SEC
Feb 26, 2026·SEC
Get notified when ACA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Arcosa, Inc. (ACA) stock FAQ — growth, dividends, profitability & financials explained
Arcosa, Inc. (ACA) reported $2.82B in revenue for fiscal year 2025. This represents a 66% increase from $1.70B in 2016.
Arcosa, Inc. (ACA) grew revenue by 12.2% over the past year. This is steady growth.
Yes, Arcosa, Inc. (ACA) is profitable, generating $222.6M in net income for fiscal year 2025 (7.2% net margin).
Yes, Arcosa, Inc. (ACA) pays a dividend with a yield of 0.14%. This makes it attractive for income-focused investors.
Arcosa, Inc. (ACA) has a return on equity (ROE) of 8.3%. This is below average, suggesting room for improvement.
Arcosa, Inc. (ACA) generated $224.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.